Global Surgical Ablation Market 2017-2021

About Surgical Ablation

Surgical ablation refers to remove or ablation of tissue from the body. Ablation procedures performed for the removal of the small- as well as large-sized tissue. There are many types of ablation procedures, and multiple techniques are used to perform the removal of tissue, depending on size and nature of the tissue. An appendectomy, the procedure to remove an infected appendix, is also considered as an ablation. Ablation procedure involves the usage of a scalpel or laparoscopic instrument to ablate the diseased appendix without affecting the healthy tissue.


Technavio’s analysts forecast the global surgical ablation market to grow at a CAGR of 7.65% during the period 2017-2021.


Covered in this report

The report covers the present scenario and the growth prospects of the global surgical ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of surgical ablation devices.


The market is divided into the following segments based on geography:

· Americas

· APAC

· EMEA


Technavio's report, Global Surgical Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors

· AngioDynamics

· Boston Scientific

· Johnson & Johnson

· Medtronic


Other prominent vendors

· Accuray

· Advanced Cardiac Therapeutics

· Arthrex

· AtriCure

· Biotronik

· BOVIE MEDICAL

· BSD Medical

· CardioFocus

· CONMED

· Estech

· Gynesonics

· Hologic

· Merit Medical Systems

· MicroPort Scientific

· OLYMPUS MEDICAL SYSTEMS (a subsidiary of OLYMPUS CORPORATION)

· Osypka Medical

· PLC Medical Systems

· RF Medical (a subsidiary of BVM Medical)

· Smith & Nephew

· St. Jude Medical (acquired by Abbott in January 2017)

· Total Vein Systems


Market driver

• Increase in prevalence/incidence of chronic disorders coupled with older population

• For a full, detailed list, view our report


Market challenge

• High cost of equipment and procedures

• For a full, detailed list, view our report


Market trend

• New product launches coupled with R&D activities

• For a full, detailed list, view our report


Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?


You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Tissue ablation: Market outline
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by procedure type
• Global surgical tumor ablation market
• Global surgical cardiac ablation market
• Global other surgical ablation market
• Market size and forecast
PART 07: Market segmentation by end-users
Hospitals
• Ambulatory surgery centers (ASCs)
• PART 08: Geographical segmentation
• Surgical ablation market in Americas
• Surgical ablation market in EMEA
• Surgical ablation market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• New product launches coupled with R&D activities
• M&A
• Increasing adoption of laparoscopic and robotic-assisted surgical ablation techniques
PART 12: Vendor landscape
PART 13: Key vendor analysis
• AngioDynamics
• Boston Scientific
• Johnson & Johnson
• Medtronic
• Other prominent vendors
PART 14: Appendix
• List of abbreviations

List of Exhibits
Exhibit 01: Global surgical ablation market 2016-2021 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: Segmentation of global surgical ablation market by procedure type 2016
Exhibit 04: Global surgical ablation market by procedure 2016-2021 ($ millions)
Exhibit 05: Global surgical ablation market by procedure 2016-2021 (%)
Exhibit 06: Global surgical ablation market by procedure 2016-2021 ($ millions)
Exhibit 07: Global surgical tumor ablation market 2016-2021 ($ millions)
Exhibit 08: Global surgical cardiac ablation market 2016-2021 ($ millions)
Exhibit 09: Global other surgical ablation market 2016-2021 ($ millions)
Exhibit 10: Segmentation of global surgical ablation market by end-users 2016
Exhibit 11: Segmentation of global surgical ablation market by geography 2016 (%)
Exhibit 12: Segmentation of global surgical ablation market by geography 2021 (%)
Exhibit 13: Global surgical ablation market by geography 2016-2021 ($ millions)
Exhibit 14: Global surgical ablation market by geography 2016-2021 (%)
Exhibit 15: Global surgical ablation market by geography 2016-2021
Exhibit 16: Surgical ablation market in Americas 2016-2021 ($ millions)
Exhibit 17: Surgical ablation market in EMEA 2016-2021 ($ millions)
Exhibit 18: Surgical ablation market in APAC 2016-2021 ($ millions)
Exhibit 19: Percentage of all cancer types globally 2012
Exhibit 20: MI versus open surgeries in developed countries 2016 (%)
Exhibit 21: MI versus open surgeries in developing nations 2016 (%)
Exhibit 22: Product recalls in energy-based surgical ablation market 2015-2017
Exhibit 23: New product launches 2015-2016
Exhibit 24: Major M&A activities in global surgical ablation market 2016–2017
Exhibit 25: Competitive structure analysis of global surgical ablation market 2016
Exhibit 26: AngioDynamics: Key highlights
Exhibit 27: AngioDynamics: Strength assessment
Exhibit 28: AngioDynamics: Strategy assessment
Exhibit 29: AngioDynamics: Opportunity assessment
Exhibit 30: Boston Scientific: Key highlights
Exhibit 31: Boston Scientific: Strength assessment
Exhibit 32: Boston Scientific: Strategy assessment
Exhibit 33: Boston Scientific opportunity assessment
Exhibit 34: Johnson & Johnson: Key highlights
Exhibit 35: Johnson & Johnson strength assessment
Exhibit 36: Johnson & Johnson: Strategy assessment
Exhibit 37: Johnson & Johnson: Opportunity assessment
Exhibit 38: Medtronic: Key highlights
Exhibit 39: Medtronic: Strength assessment
Exhibit 40: Medtronic: Strategy assessment
Exhibit 41: Medtronic: Opportunity assessment